Archive for the ‘Cancer’ Category

METHODS After approval from the Hamilton Health Sciences Research Ethics Board, a retrospective search was conducted using the health records of Hamilton Health Sciences, McMaster University and the Juravinski Cancer Centre (Hamilton, Ontario) to identify patients who underwent lumpectomy and radiation (with or without chemotherapy) for breast cancer with subsequent bilateral reduction mammoplasty between 1980 […]

Symptoms of breast hypertrophy can affect post-treatment breast cancer patients. The true incidence of breast hypertrophy in the breast cancer population is unknown, as is the number of such patients seeking reduction mammoplasty surgery following breast cancer treatment. These patients have usually undergone lumpectomies followed by postoperative radiation therapy and chemotherapy. Although there can be […]

White’s group, along with colleagues from the University of Southern California School of Medicine, Los Angeles, has been working with a human-derived monoclonal antibody (which may be used on routinely processed, paraffin-embedded tissue) that is directed against a cytoplasmic, rather than a cell-surface, antigen. The researchers hope was that this monoclonal antibody, which White said […]

Overall, the group had 181 times the chance of getting melanoma as persons in the general population, he said, with the risk per group broken down this way: Type A had, as stated, little increased risk; В had 228 times the risk; С had 162, D1 had 441—and in the D2 group, the risk was […]

The ranking is as follows: • Tyре A: No personal or family history of melanoma; moles do not run in family (sporadic dysplastic nevus syndrome). • Type B: No personal or family history of melanoma; moles run in family. • Type C: Personal or family history of melanoma; moles do not run in family. • […]

THE CASE AGAINST dysplastic nevi, long considered suspects in the malignant melanoma mystery, appears to be growing stronger based on new evidence. These atypical pigmented moles have been identified as frequent precursors of the worst form of skin cancer in individuals and families where they flourish. At the annual meeting in New Orleans of the […]

Questioned on this point, Hurwitz said he stands by his guidelines, explaining: “I wrote the textbook in 1980 [Clinical Pediatric Dermatology. Philadelphia, WB Saunders Co] that said skin cancer, including melanoma, in children is rare. We have now reversed that because it isn’t that uncommon.” Although many dermatologists stress this fact, offering case reports as […]